FSCN1 and breast carcinoma: Evaluating the effect of manipulating some of the dysregulated metabolites on breast cancer cell proliferation, migration and invasion in the context of fascin expression would strengthen the link between fascin-mediated dysregulation of these metabolites and the observed functions.